Syneos Health

Large Pharma Clinical Development and Commercialization for Global Biopharmaceutical Leaders

Large pharmaceutical organizations require consistency, transparency and scalability. Syneos Health supports enterprise ...
syneoshealth

Strengthening Clinical Rigor in Psychedelic Development: Ensuring Patient Safety, Treatment Consistency and Operational Excellence

Psychedelic therapies are advancing toward potential regulatory review and commercialization, creating new expectations for how clinical programs are designed, executed and evaluated. Unlike ...
syneoshealth

Benchmarking Study Finds Clinical Trial Performance Is Shaped by Operating Model Design, Not Sourcing Strategy

Article highlights insight from Brittany Ahmed, M.D., Medical Director, Medical & Scientific Management, Syneos Health; Anna La Noce, M.D., Executive Medical Director ...
syneoshealth

Editor’s Letter: Taking Talent to the Next Level

Article highlights insight from Brittany Ahmed, M.D., Medical Director, Medical & Scientific Management, Syneos Health; Anna La Noce, M.D., Executive Medical Director ...
syneoshealth

There Is No Such Thing as a Typical Biotech

Article highlights insight from Brittany Ahmed, M.D., Medical Director, Medical & Scientific Management, Syneos Health; Anna La Noce, M.D., Executive Medical Director ...
syneoshealth

Biopharma challenges leaders want to tackle

Article highlights insight from Brittany Ahmed, M.D., Medical Director, Medical & Scientific Management, Syneos Health; Anna La Noce, M.D., Executive Medical Director ...
syneoshealth

Muaiad Kittaneh: Why “What’s Next” Isn’t Always What Oncology Needs For Innovation

Article highlights insight from Brittany Ahmed, M.D., Medical Director, Medical & Scientific Management, Syneos Health; Anna La Noce, M.D., Executive Medical Director ...
syneoshealth

Muaiad Kittaneh: Oncology Development Moving Beyond Traditional Protocol Execution

Article highlights insight from Brittany Ahmed, M.D., Medical Director, Medical & Scientific Management, Syneos Health; Anna La Noce, M.D., Executive Medical Director ...
syneoshealth

Mitigating Manufacturers’ Exposure to Us Mfn Policy Through European Repricing

Article highlights insight from Brittany Ahmed, M.D., Medical Director, Medical & Scientific Management, Syneos Health; Anna La Noce, M.D., Executive Medical Director ...
syneoshealth

Building Long-Term Value Through Functional Service Provider Partnerships

Article highlights insight from Brittany Ahmed, M.D., Medical Director, Medical & Scientific Management, Syneos Health; Anna La Noce, M.D., Executive Medical Director ...
syneoshealth

MRD as a Decision Engine: Rethinking Oncology Trial Design from Early Phase to Registration

Article highlights insight from Brittany Ahmed, M.D., Medical Director, Medical & Scientific Management, Syneos Health; Anna La Noce, M.D., Executive Medical Director ...
syneoshealth

AHA Scientific Sessions 2026

Cardiovascular drug development requires specialized expertise to navigate increasingly complex trial designs, evolving regulatory expectations and diverse patient populations across acute, chronic ...